ServiziMenu principaleHome
You are here: Home > What we do > Past events > 2020 > 8th ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology
Share on Share on Facebook Twitter Share on Linkedin Share on WhatsApp Share on Instagram Share by email Print this page

8th ESO-ESMO Arab and Southern European Countries Masterclass in Clinical Oncology

30 ESCO credits

23.01.2020  -  27.01.2020

Limassol, Cyprus


Medical / clinical oncology


Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY

This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, gynaecological, lung, urological and gastrointestinal cancers. Spotlight sessions will facilitate compact update on head and neck, melanoma, elderly patients, soft tissue sarcoma, non-Hodgkin lymphoma cancer of unknown primary, supportive care and the role of informal supporter.

The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.

• Full immersion
• 3-and-a-half-day residential event
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung, urological and gastrointestinal cancers.

Held under the auspices of the           

In this review, the authors summarize the history of the 41 Masterclasses in Clinical Oncology (MCO) organized by ESO or ESO-ESMO during the last 17 years. The MCO has become a major educational event of ESO, intending to educate young oncologists from various countries within or outside Europe, providing an up-to-date interactive program based on solid evidence for all presented topics.
"Reprinted from Critical Reviews in Oncology / Hematology, Pavlidis et al, Copyright (2019)
https://doi.org/10.1016/j.critrevonc.2019.07.022 with permission from Elsevier”

Download PDF document


M.S. Aapro, Clinique de Genolier, CH
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Azim jr, American University of Beirut, LB
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
S. Cascinu, Università di Modena e Reggio Emilia, Modena, IT
G. Ceresoli, Humanitas Gavazzeni, Bergamo, IT
A. Charalambous, Cyprus University of Technology, Limassol, CY
A. Constantinidou, University of Cyprus, Medical School, Nicosia, CY
A. Eniu, Cancer Institute « I. Chiricuta”, Cluj-Napoca, RO
F. Geara, American University of Beirut, LB
H. Gogas, University of Athens, Athens, GR
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
P. Kountourakis, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, Ioannina School of Medicine, GR
G. Pruneri, European Institute of Oncology, Milan, IT
J. Remon-Masip, Centro Integral Oncología Clara Campal (CIOCC), Barcelona, ES
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
S. Temraz, American University of Beirut, LB
J.B. Vermorken, Antwerp University Hospital, BE

General information

European School of Oncology
Dolores Knupfer
Piazza Indipendenza 2
6500 Bellinzona
Ph +41 91 820 0951 or 52, Fx +41 91 820 0953
Email: dknupfer@eso.net

Alice Ciocchini, aciocchini@eso.net, ph +39 02 85464529

Travel support will be made available as a contribution to travel expenses, to admitted participants coming from lower-middle- income countries as defined by the World Bank.

Participants will receive their certificate of attendance via e-mail after the event on completion of the evaluation form.
The programme is furthermore accredited with 25 ESMO-MORA category 1 points.


• Age below 40 years
• At least 2-3 years’ experience in medical or clinical oncology
• Involvement in scientific activities (preferable)
• Intermediate level of English

Priority will be given to suitable applicants working in Arab and Southern European countries.

Participants will be asked to bring their personal laptop or tablet (wireless enabled) to the Masterclass as an event-dedicated website will be created and all questionnaires and certificates will be accessible only from there.

Successful applicants are granted free registration and accommodation


23 January

    Participants’ arrival and dinner                     


24 January

8:00   Registration
8:45   Welcome address
M.S. Aapro, CH - N. Pavlidis, GR
Chairs: J. Khader, JO - N. Mottet, FR
9:00   Management including active surveillance of localized prostate cancer
J. Khader, JO
9:25   Discussion
9:30   Key topics in locally advanced, advanced and metastatic prostate cancer
N. Mottet, FR
9:55   Discussion
10:00   Update in the management of bladder cancer
J. Khader, JO
10:25   Discussion
10:30   Coffee break
11:00   Update in the management of renal cancer
N. Mottet, FR
11:25   Discussion
11:30   Management of relapsed testicular cancer
S. Temraz, LB
12:00   Urological Cancers Tumor Board (4 cases)
13:00   Lunch break
Chairs: G. Ceresoli, IT - F. Geara, LB
14:00   The impact of radiation therapy in lung cancer
F. Geara, LB
14:25   Discussion
14:30   Neoadjuvant and adjuvant systemic treatment in NSCLC
G. Ceresoli, IT
14:55   Discussion
15:00   Systemic chemotherapy and targeted treatment in metastatic NSCLC
J. Remon-Masip, ES
15:25   Discussion
15:30   Coffee break
16:00   Immune check point inhibitors in NSCLC
J. Remon-Masip, ES
16:25   Discussion
16:30   Systemic therapy of small-cell lung cancer
G. Ceresoli, IT
16:55   Discussion
17:00   Systemic management of advanced mesothelioma
G. Ceresoli, IT
17:25   Discussion
17:30   Lung Cancer Tumor Board (4 cases)
20:00   Dinner


25 January

Chairs: P. Kountourakis CY – S. Cascinu, IT
 8:30   Adjuvant / neoadjuvant systemic treatment in colorectal  cancer 
P. Kountourakis CY
8:55   Discussion
 9:00   Systemic treatment in advanced colon cancer
S. Cascinu, IT
 9:25   Discussion
 9:30   Radiation treatment in rectal cancer
J. Khader, JO 
9:55   Discussion
10:00   Systemic treatment in early and advanced gastric cancer
S. Cascinu, IT
10:25   Discussion
10:30   Coffee break
11:00   Gastrointestinal Cancers Tumor Board (4 cases)
12:00   Lunch
13:00   Modern management of melanoma
H. Gogas, GR 
13:25   Discussion
13:30   Cancer of unknown primary
N. Pavlidis, GR
13:55   Discussion
14:00   How do I manage cancer in elderly patients
M.S. Aapro, CH
14:25   Discussion
14:30   The role of informal supporter
A. Charalambous, CY
14:50   Discussion
15:00   Update in the management of high-grade NHL
A. Stathis, CH
15:25   Discussion
15:30   Coffee break
16:00   Parallel Group Sessions I (Cases discussion in three groups)


26 January

Chairs: J. Gligorov, FR - H. Azim, EG
8:30   What the clinician needs to know from the breast pathologist 
G. Pruneri, IT
8:55   Discussion
9:00   Current controversies/challenges in breast surgery
M.J. Cardoso, PT
9:25   Discussion
9:30   The role of radiotherapy in e arly and locally advancedbreast cancer
R. Orecchia, IT
9:55   Discussion
10:00   Genomic testing in breast cancer
H. Azim jr, LB
10:25   Discussion
10:30   Coffee Break
11:00   Neoadjuvant/adjuvant chemotherapy and biological agents
A. Eniu, RO
11:25   Discussion
11:30   Neoadjuvant/adjuvant endocrine therapy
J. Gligorov, FR
11:55   Discussion
12:00   Management of HER2+ advanced breast cancer
A. Eniu, RO
12:25   Discussion
12:30   Management of triple-negative advanced breast cancer
H. Azim, EG
12:55   Discussion
13:00   Management of ER+ advanced breast cancer
J. Gligorov, FR
13:25   Discussion
13:30   Lunch Break
14:30   Breast Cancer Tumor Board (4 cases)
15:30   Supportive care
M.S. Aapro, CH
15:55   Discussion
16:00   Update in the management of soft tissue sarcomas
A. Constantinidou, CY
16:25   Discussion
16:30   Coffee break
17:00   Parallel Group Sessions II (Case discussion in three groups)


27 January

Chairs: A. Constantinidou, CY - J.B. Vermorken, BE                
 8:00   Systemic management of ovarian cancer
J.B. Vermorken, BE
8:25   Discussion
8:30   Systemic management of locally advanced or metastatic cervical and endometrial cancer
J.B. Vermorken, BE
8:55   Discussion
9:00   Gynecological Cancers Tumor Board (4 cases)
10:00   Coffee break
10:30   Update in the management of head and neck cancer
J.B. Vermorken, BE
10:55   Discussion
 11:00   Learning self-assessment test
11:45   Closing remarks amd awards